Priveterra Acquisition initial business combination with AEON Biopharma
We are advising Priveterra on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
TMS ¥2.9 billion global IPO
The shares are listed on the Tokyo Stock Exchange
Metalmark Capital up to $50 million investment in Morgenesis
We advised Metalmark on the transaction
Molded Devices acquisition of GlobalMed and Schauenburg-Truplast
We advised Molded Devices on the acquisition and the related financing arrangements
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Novo Nordisk $1.1 billion acquisition of Forma Therapeutics
We are advising Novo Nordisk on the transaction
Freeman Spogli investment in EverVet
We advised Tailwind Capital and EverVet on the transaction
Gilead Sciences $405 million acquisition of MiroBio
We are advising Gilead Sciences on the transaction
TPG Capital $1.1 billion take-private acquisition of Convey Health Solutions
We are advising TPG Capital on the transaction